GO:0006913 nucleocytoplasmic transport: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006913 nucleocytoplasmic transport is the directed movement of molecules between the nucleus and the cytoplasm, mediated by nuclear pore complexes and soluble transport receptors.
• Import and export are signal-dependent: nuclear localization signals (NLS) and nuclear export signals (NES) are recognized by importins and exportins in a RanGTP gradient.
• The Ran GTPase cycle provides directionality, with RanGEF (RCC1) nuclear and RanGAP cytoplasmic.
• Defects in nucleocytoplasmic transport are increasingly linked to neurodegeneration, including ALS/FTD, and to viral interference.
• SUMOylation and other post-translational modifications regulate cargo recognition and transport factor function.
• CRISPR knockout, point mutation, knock-in and overexpression models enable causal testing of transport genes in disease and basic biology.
Description
Nucleocytoplasmic transport (GO:0006913) is the directed movement of molecules between the nucleus and the cytoplasm, a process essential for gene expression, signal transduction and cellular homeostasis. This bidirectional traffic occurs through nuclear pore complexes (NPCs) and relies on soluble transport receptors that recognize cargo signals and shuttle across the nuclear envelope. The field has matured from early inventories of transport factors to detailed mechanistic and structural models of how cargoes are recognized, translocated and released. Because transport controls the access of transcription factors, RNA-binding proteins and viral components to the nucleus, its dysfunction has broad implications for human disease. This article summarizes the definition, mechanism, key genes, disease links and research methods for GO:0006913, with a focus on how CRISPR-based models can be used to interrogate this process.
nucleocytoplasmic transport At A Glance
| GO ID | GO:0006913 |
|---|---|
| GO term | nucleocytoplasmic transport |
| Ontology | biological_process |
| Synonym | nucleocytoplasmic shuttling |
| Definition | The directed movement of molecules between the nucleus and the cytoplasm. |
| Major function | Bidirectional transport of proteins and RNAs across the nuclear envelope |
| Key machinery | Nuclear pore complexes, importins, exportins, Ran GTPase |
| Directionality | RanGTP gradient maintained by RCC1 (nuclear) and RanGAP (cytoplasmic) |
| Disease relevance | Neurodegeneration, viral infection, cancer |
What Is GO:0006913?
According to the Gene Ontology, GO:0006913 nucleocytoplasmic transport is defined as the directed movement of molecules between the nucleus and the cytoplasm. This includes the import of proteins and RNAs into the nucleus and their export to the cytoplasm, as well as the shuttling of macromolecules across the nuclear envelope. The term encompasses signal recognition, translocation through nuclear pore complexes and release of cargo in the appropriate compartment.
Why Is nucleocytoplasmic transport Important in Cell Biology?
Nucleocytoplasmic transport is fundamental to eukaryotic cell biology because it controls the spatial distribution of macromolecules and thereby regulates gene expression, cell cycle progression and stress responses. Defects in this process are increasingly recognized as contributors to neurodegeneration, including amyotrophic lateral sclerosis and frontotemporal dementia, and are targeted by viruses to evade host defenses. Understanding the molecular players and regulatory mechanisms is therefore critical for both basic research and therapeutic development.
• Controls nuclear access of transcription factors and RNA-binding proteins, influencing gene expression programs.
• Maintains the RanGTP gradient that provides directionality to import and export.
• Dysregulation is linked to neurodegenerative diseases such as ALS/FTD.
• Viruses interfere with nucleocytoplasmic transport to promote replication and immune evasion.
• SUMOylation regulates transport factors and cargo recognition.
• Nuclear pore complex components are mutated in some cancers and developmental disorders.
• Provides targets for antiviral and neuroprotective therapeutic strategies.
• Essential for RNA export and quality control, impacting transcriptome fidelity.
What Happens During nucleocytoplasmic transport?
Cargo recognition and signal sequences
In simple terms: Proteins that need to enter or leave the nucleus carry molecular tags that tell the transport machinery where they belong.
Nuclear localization signals (NLS) and nuclear export signals (NES) are short amino acid motifs recognized by importins and exportins, respectively. These signals can be constitutive or regulated by post-translational modifications such as phosphorylation and SUMOylation, allowing dynamic control of cargo distribution.
Translocation through the nuclear pore complex
In simple terms: The nuclear pore complex is a large channel that lets cargo-carrying transport receptors pass through the nuclear envelope.
Nuclear pore complexes (NPCs) are large protein assemblies that form aqueous channels across the nuclear envelope. Transport receptors bound to cargo interact with nucleoporins containing phenylalanine-glycine (FG) repeats, facilitating translocation. The NPC acts as a selective barrier, permitting rapid passage of transport complexes while restricting most other macromolecules.
The Ran GTPase cycle and directionality
In simple terms: A gradient of the Ran protein across the nuclear envelope acts like a compass, telling import and export receptors which way to go.
Ran is a small GTPase that is predominantly GTP-bound in the nucleus and GDP-bound in the cytoplasm due to the localization of its regulators RCC1 (RanGEF) and RanGAP. Importins bind cargo in the cytoplasm and release it in the nucleus upon RanGTP binding, while exportins bind cargo and RanGTP in the nucleus and release them in the cytoplasm after GTP hydrolysis. This gradient provides the directionality for nucleocytoplasmic transport.
Cargo release and recycling
In simple terms: Once the cargo reaches the right compartment, it is released and the transport receptors are recycled for another round.
In the nucleus, RanGTP binding to importins causes conformational changes that release the cargo. Export complexes are disassembled in the cytoplasm upon RanGAP-mediated GTP hydrolysis, releasing the cargo and allowing exportins to be re-imported. This cycle ensures efficient recycling of transport factors and maintains steady-state distribution of cargoes.
Key Genes Involved in GO:0006913 nucleocytoplasmic transport
The following genes and proteins are central to nucleocytoplasmic transport, as documented in the literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAN | Ran GTPase; provides directionality | Core regulator of import/export; mutations affect gradient |
| RCC1 | Ran guanine nucleotide exchange factor (RanGEF) | Nuclear RanGTP generation; cell cycle regulation |
| RANGAP1 | Ran GTPase-activating protein (RanGAP) | Cytoplasmic RanGDP generation; transport directionality |
| KPNB1 | Importin beta-1; nuclear import receptor | Mediates import of NLS-containing cargoes |
| KPNA1 | Importin alpha-1; adaptor for NLS cargo | Binds NLS and importin beta for import |
| XPO1 | Exportin-1 (CRM1); nuclear export receptor | Exports NES-containing proteins and RNAs |
| CSE1L | Exportin-2; imports importin alpha | Recycles importin alpha |
| NUP98 | Nucleoporin; NPC component | Fusion proteins in leukemia; transport regulation |
| NUP62 | Nucleoporin; central channel | NPC barrier function; viral interactions |
| NUP153 | Nucleoporin; nuclear basket | Docking and export; regulated by SUMO |
| NUP214 | Nucleoporin; cytoplasmic filaments | Fusion in leukemia; export regulation |
| NUP88 | Nucleoporin; cytoplasmic side | NPC assembly and cancer |
| RANBP2 | Nucleoporin; SUMO E3 ligase | SUMOylation and transport regulation |
| TNPO1 | Transportin-1; import receptor | Imports hnRNP proteins; ALS link |
| IPO7 | Importin-7; import receptor | Imports ribosomal proteins and histones |
| XPO5 | Exportin-5; exports miRNAs | RNA export; viral interference |
| NUP358 | Nucleoporin; RanBP2 | SUMOylation and NPC function |
How Is nucleocytoplasmic transport Regulated?
Nucleocytoplasmic transport is regulated at multiple levels, including post-translational modifications of transport factors and nucleoporins. SUMOylation of nucleoporins and transport receptors modulates their interactions and localization, thereby influencing cargo selection and transport efficiency. Phosphorylation of importins and exportins can alter their affinity for cargo or Ran. Additionally, the RanGTP gradient is dynamically regulated during the cell cycle and in response to stress, affecting the distribution of key regulatory proteins. Viral proteins can also interfere with transport regulation to favor viral replication.
nucleocytoplasmic transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| C9orf72 | ALS/FTD; transport defects from dipeptide repeats | Knock-in of repeat expansion in iPSCs or mice |
| NUP98 | Leukemia; fusion proteins | Knock-in of NUP98 fusion in hematopoietic cells |
| XPO1 | Cancer; overexpression and export dysregulation | Knockout or point mutation in cancer cell lines |
| RAN | Neurodegeneration; gradient disruption | Point mutation of Ran GTPase in neurons |
| TNPO1 | ALS; impaired import of hnRNP proteins | Knockout in motor neurons |
Neurodegeneration and ALS/FTD
Disrupted nucleocytoplasmic transport is a hallmark of several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). In C9orf72-mediated ALS/FTD, repeat expansions lead to dipeptide repeat proteins that impair nucleocytoplasmic transport, contributing to neuronal dysfunction. Transport defects may be a cause or consequence of neurodegeneration, and restoring transport function is a potential therapeutic strategy.
Viral interference with nucleocytoplasmic transport
Many viruses encode proteins that target nuclear pore complexes or transport receptors to block host antiviral responses and promote viral replication. For example, viral proteins can inhibit nuclear import of transcription factors such as NF-kB or interfere with RNA export. Understanding these mechanisms provides insights for antiviral drug development.
Cancer and nucleoporin fusions
Chromosomal translocations involving nucleoporins, such as NUP98 and NUP214, produce fusion proteins that alter gene expression and are associated with leukemia. Dysregulated nuclear export, often via XPO1 overexpression, is observed in various cancers and is a target for exportin inhibitors.
From nucleocytoplasmic transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of RAN affect cell viability? | CRISPR knockout of RAN in cell lines |
| How do point mutations in RCC1 alter Ran gradient? | Point mutation knock-in of RCC1 |
| Can NUP98 fusion drive leukemia? | Knock-in of NUP98 fusion in hematopoietic stem cells |
| Does overexpression of XPO1 promote tumor growth? | Overexpression of XPO1 in cancer cell lines |
| Where does TNPO1 localize in neurons? | Tagged knock-in of TNPO1 with fluorescent tag |
| What genes are essential for nucleocytoplasmic transport? | Genome-wide CRISPR library screening |
How to Study the nucleocytoplasmic transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Localization and dynamics of transport factors | Live-cell imaging of import/export |
| Proteomics | Protein interactions and cargo identification | Mapping importin/exportin interactomes |
| CRISPR knockout screens | Genes required for transport | Identifying novel regulators |
| RNA-seq | Transcriptional changes upon transport perturbation | Assessing gene expression effects |
| Biochemical GTPase assays | Ran GTP hydrolysis and exchange | Mechanistic studies of directionality |
| Nuclear export reporter assays | Export efficiency of NES-containing cargo | Testing export inhibitors |
| Single-molecule imaging | Transport receptor dynamics at NPC | Detailed kinetic analysis |
Fluorescence microscopy and live-cell imaging
Fluorescence microscopy using GFP-tagged transport factors or cargoes allows visualization of nuclear import and export in real time. Live-cell imaging can quantify transport kinetics and the effects of mutations or drugs.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry can identify cargoes and interacting partners of importins and exportins. Proximity labeling approaches can map the nucleoporin interactome.
RNA interference and CRISPR screens
High-throughput RNAi or CRISPR knockout screens can identify genes required for nucleocytoplasmic transport or for the nuclear localization of specific reporters. These screens are powerful for discovering novel regulators.
Biochemical assays for Ran GTPase activity
In vitro assays using recombinant Ran and its regulators can measure GTP hydrolysis and nucleotide exchange rates. Such assays help dissect the mechanism of directionality.
How CRISPR Can Be Used to Study GO:0006913 nucleocytoplasmic transport
Knockout
CRISPR knockout of genes such as RAN, RCC1, or XPO1 can reveal their essential roles in nucleocytoplasmic transport and cell viability. Knockout cell lines are valuable for studying loss-of-function phenotypes and for validating drug targets.
Point Mutation
Introducing point mutations in transport factors, such as Ran GTPase mutants, allows precise dissection of GTP binding and hydrolysis in transport directionality. Point mutations can also model disease-associated variants found in patients.
Knock-in
Knock-in of fusion genes like NUP98-NUP214 or of tagged transport factors enables disease modeling and visualization of protein localization in a physiological context. Tagged knock-in lines are useful for live-cell imaging.
Overexpression
Overexpression of exportins such as XPO1 or of cargo proteins can mimic pathological states and test whether increased transport activity drives disease phenotypes. Overexpression models are also used to study viral interference with transport.
How EDITGENE Supports nucleocytoplasmic transport Research
Researchers studying nucleocytoplasmic transport-related genes often need to determine whether a candidate gene is causally involved in transport regulation or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for nucleocytoplasmic transport research.
Frequently Asked Questions About nucleocytoplasmic transport
What is nucleocytoplasmic transport?
Nucleocytoplasmic transport (GO:0006913) is the directed movement of molecules between the nucleus and the cytoplasm, mediated by nuclear pore complexes and transport receptors.
What genes are involved in nucleocytoplasmic transport?
Key genes include RAN, RCC1, RANGAP1, KPNB1, XPO1, and nucleoporins such as NUP98 and NUP62.
How does the Ran gradient work in nucleocytoplasmic transport?
RanGTP is enriched in the nucleus due to RCC1, while RanGDP is cytoplasmic due to RanGAP; this gradient determines the direction of import and export.
What diseases are linked to nucleocytoplasmic transport defects?
Neurodegenerative diseases such as ALS/FTD, certain leukemias, and viral infections are associated with transport defects.
What is the role of nuclear pore complexes in transport?
Nuclear pore complexes form channels that allow transport receptors to carry cargo across the nuclear envelope.
How can CRISPR be used to study nucleocytoplasmic transport?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of transport genes and disease variants.
What is the difference between importins and exportins?
Importins bind NLS-containing cargo for nuclear import, while exportins bind NES-containing cargo and RanGTP for nuclear export.
How is nucleocytoplasmic transport regulated?
It is regulated by post-translational modifications such as SUMOylation and phosphorylation, and by the RanGTP gradient.
What methods are used to study nucleocytoplasmic transport?
Fluorescence microscopy, proteomics, CRISPR screens, and biochemical assays are commonly used.
Why is nucleocytoplasmic transport important for viral infection?
Viruses often interfere with transport to block host immune responses and promote replication.
Conclusion
Nucleocytoplasmic transport (GO:0006913) is a fundamental biological process that controls the distribution of macromolecules between the nucleus and cytoplasm. Its dysregulation is implicated in neurodegeneration, cancer, and viral pathogenesis, making it a rich area for research. Advances in CRISPR-based models and screening technologies are enabling precise interrogation of transport mechanisms and disease links. EDITGENE offers comprehensive services to support these studies, from knockout to overexpression and bioinformatics analysis.
References
- 1. Mobbs GW et al.. 2026. Nucleocytoplasmic Transport.. Annu Rev Biochem 95(1):247-290 PMID: 41955616
- 2. Hutten S et al.. 2020. Nucleocytoplasmic transport defects in neurodegeneration - Cause or consequence?. Semin Cell Dev Biol 99:151-162 PMID: 31152789
- 3. Ptak C et al.. 2017. SUMO and Nucleocytoplasmic Transport.. Adv Exp Med Biol 963:111-126 PMID: 28197909
- 4. Ding B et al.. 2021. Nucleocytoplasmic Transport: Regulatory Mechanisms and the Implications in Neurodegeneration.. Int J Mol Sci 22(8) PMID: 33920577
- 5. Chien CY et al.. 2025. Viral interference of nucleocytoplasmic transport.. J Biol Chem 301(12):110815 PMID: 41101500
- 6. Sorokin AV et al.. 2007. Nucleocytoplasmic transport of proteins.. Biochemistry (Mosc) 72(13):1439-57 PMID: 18282135
- 7. Zhang K et al.. 2016. Nucleocytoplasmic transport in C9orf72-mediated ALS/FTD.. Nucleus 7(2):132-7 PMID: 27116041
- 8. Fried H et al.. 2003. Nucleocytoplasmic transport: taking an inventory.. Cell Mol Life Sci 60(8):1659-88 PMID: 14504656
